Garadacimab (CSL312) represents a pioneering advancement as a fully human IgG4 monoclonal antibody that specifically targets activated factor XII (FXIIa). This unique specificity renders it a valuable tool for investigating the pathophysiology and potential therapeutic interventions for hereditary angioedema.
Garadacimab (CSL312) represents a pioneering advancement as a fully human IgG4 monoclonal antibody that specifically targets activated factor XII (FXIIa). This unique specificity renders it a valuable tool for investigating the pathophysiology and potential therapeutic interventions for hereditary angioedema.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
